Opinion · 3 Apr 2025
Conference abstractPublished 1 Sep 2017
Nanoparticle-based vaccine platforms against apicomplexan
University Tours, France
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Vaccines based on live attenuated parasites are associated with safety concerns related to reversion to pathogenic form or recombination with wild strains, are expensive, require a cold storage for delivery, are difficult to manufacture and have a short shelf life. Subunit vaccines are more stable and safer but they have lower efficiency. Optimal progress towards novel vaccines against intracellular apicomplexan parasites will depend on several factors such as selection of appropriate parasite antigens and optimal presentation of these antigens to the immune system, including identification of the best adjuvant formulation and route of vaccine administration. Due to the complexity of apicomplexan parasites, vaccine strategies must associate large panel of antigens and adjuvant able to better stimulate innate and adaptive immune responses than in natural infection. Toll-Like Receptors are expressed on numerous cells of the immune system and TLR agonists are promising adjuvants also in farm animals. Mucosal administration of vaccines, by mimicking natural route of infection, is an important approach to induce appropriate protective immune responses to microbial antigens in systemic sites and peripheral blood as well as in most mucosal environments. Our team has demonstrated that maltodextrin/phospholipid nanoparticles sustain release of all soluble components of Toxoplasma gondii after nasal administration. This formulation led to protection against congenital toxoplasmosis in mice (70% reduction in parasite load) and chronic toxoplasmosis in ewes (no parasite detected) correlated with strong and long-lasting humoral and Th1/Th17 cellular responses (Dimier-Poisson et al. 2015, Ducournau et al. 2017, and unpublished data). We now apply this vaccine strategy against an emerging cause of abortion and infertility problems in cattle, neosporosis due to Neospora caninum. TLR ligands are added as adjuvant to reach sterilizing vaccine.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
Rational design of a fully synthetic nanoparticle-based vaccine
Article · 28 Feb 2025
Nanoparticle-Based Biosensors for Real-Time Detection of Infectious Diseases
Article · 31 Jan 2025
Nanoparticle-Based Virotherapy for Targeted Treatment of Human Papillomavirus (HPV) Related Cancers
Short communication · 25 Nov 2024
Tackling Drug Resistance: Nanoparticle-Based Co-Delivery of Biotherapeutics and Chemotherapeutics
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectNanotechnology
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Francoise Debierre-Grockiego”
